ID17860A - Komposisi vaksin - Google Patents

Komposisi vaksin

Info

Publication number
ID17860A
ID17860A IDP972672A ID972672A ID17860A ID 17860 A ID17860 A ID 17860A ID P972672 A IDP972672 A ID P972672A ID 972672 A ID972672 A ID 972672A ID 17860 A ID17860 A ID 17860A
Authority
ID
Indonesia
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Application number
IDP972672A
Other languages
English (en)
Indonesian (id)
Inventor
Cohen Dr Joseph
Original Assignee
Smith Kline Beecham Biolog S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Beecham Biolog S A filed Critical Smith Kline Beecham Biolog S A
Publication of ID17860A publication Critical patent/ID17860A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP972672A 1996-08-02 1997-07-31 Komposisi vaksin ID17860A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9616351.4A GB9616351D0 (en) 1996-08-02 1996-08-02 Vaccine composition

Publications (1)

Publication Number Publication Date
ID17860A true ID17860A (id) 1998-01-29

Family

ID=10797980

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972672A ID17860A (id) 1996-08-02 1997-07-31 Komposisi vaksin

Country Status (32)

Country Link
US (2) US20020172692A1 (pl)
EP (2) EP1623720A3 (pl)
JP (1) JP2000517295A (pl)
KR (1) KR20000029747A (pl)
CN (1) CN1241639C (pl)
AP (1) AP1166A (pl)
AR (1) AR008799A1 (pl)
AT (1) ATE394119T1 (pl)
AU (1) AU706303B2 (pl)
BG (1) BG63290B1 (pl)
BR (1) BR9710913A (pl)
CA (1) CA2262402A1 (pl)
CO (1) CO4650186A1 (pl)
CZ (1) CZ290826B6 (pl)
DE (1) DE69738672D1 (pl)
DZ (1) DZ2283A1 (pl)
EA (1) EA002167B1 (pl)
GB (1) GB9616351D0 (pl)
ID (1) ID17860A (pl)
IL (1) IL128318A (pl)
MA (1) MA24291A1 (pl)
MY (1) MY116128A (pl)
NO (1) NO319844B1 (pl)
OA (1) OA10969A (pl)
PE (1) PE97298A1 (pl)
PL (1) PL188741B1 (pl)
SK (1) SK282438B6 (pl)
TR (1) TR199900195T2 (pl)
UA (1) UA68336C2 (pl)
UY (1) UY24654A1 (pl)
WO (1) WO1998005355A1 (pl)
ZA (1) ZA976815B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915204D0 (en) * 1999-06-29 1999-09-01 Smithkline Beecham Biolog Vaccine
US8232255B2 (en) 2002-10-23 2012-07-31 Glaxosmithkline Biologicals S.A. Methods for vaccinating against malaria
US8637463B2 (en) * 2003-12-01 2014-01-28 Meiji Dairies Corporation Peptide inhibiting angiotensin converting enzyme
GB0513421D0 (en) * 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
BRPI0614254A2 (pt) * 2005-08-02 2011-03-15 Novartis Vaccines & Diagnostic redução de interferência entre adjuvantes contendo óleo e antìgenos contendo tensoativos
JP5222289B2 (ja) 2006-07-18 2013-06-26 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム マラリア用ワクチン
GB0614254D0 (en) * 2006-07-18 2006-08-30 Smithkline Beecham Biolog Vaccine
SI2097102T1 (sl) 2006-09-07 2012-09-28 Glaxosmithkline Biolog Sa Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
CL2008002361A1 (es) 2007-08-13 2009-08-07 Glaxosmithkline Biologicals Sa Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
JP2011507816A (ja) * 2007-12-21 2011-03-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム マラリア用ワクチン
AP2010005294A0 (en) 2007-12-24 2010-06-30 Glaxosmithkline Biolog Sa Vaccines for malaria
US20120015000A1 (en) * 2008-06-30 2012-01-19 David Lanar Malaria vaccine of self-assembling polypeptide nanoparticles
EP3351266A1 (en) * 2009-11-05 2018-07-25 The United States of America as represented by the Secretary of the Navy Plasmodium falciparum sporozoite and liver stage antigens
BR112013004582A2 (pt) 2010-09-27 2016-09-06 Crucell Holland Bv método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
WO2013074501A1 (en) 2011-11-14 2013-05-23 Crucell Holland B.V. Heterologous prime-boost immunization using measles virus-based vaccines
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN104338129B (zh) * 2013-07-26 2017-05-24 中国科学院上海巴斯德研究所 雷帕霉素作为疫苗佐剂的用途及制备方法
CA3045952A1 (en) 2016-12-07 2018-06-14 Glaxosmithkline Biologicals Sa Novel process
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB2600652B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel compositions
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3280028D1 (en) * 1981-05-21 1989-12-28 Wellcome Found Protozoal antigen
PT82282B (pt) * 1985-03-28 1988-02-17 Univ New York Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
GB9012580D0 (en) * 1990-06-06 1990-07-25 Univ Nijmegen Novel protein
FR2679776A1 (fr) * 1991-07-31 1993-02-05 Pasteur Institut Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
JP3954643B2 (ja) * 1991-11-16 2007-08-08 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム マラリア原虫由来のＣＳおよびＨＢｓＡＧ間のハイブリッド蛋白質
US6169171B1 (en) * 1992-02-27 2001-01-02 Smithkline Beecham Biologicals (S.A.) Hybrid protein between CS from plasmodium and HBSAG
DE69313134T2 (de) * 1992-06-25 1998-02-26 Smithkline Beecham Biolog Adjuvantien enthaltende impfstoffzusammensetzung
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AUPM368994A0 (en) * 1994-02-04 1994-02-24 Saramane Pty Ltd Malaria merozoite antigen subunit vaccine
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

Also Published As

Publication number Publication date
BG63290B1 (bg) 2001-09-28
DE69738672D1 (de) 2008-06-19
US20020172692A1 (en) 2002-11-21
JP2000517295A (ja) 2000-12-26
UY24654A1 (es) 2001-08-27
MA24291A1 (fr) 1998-04-01
EP0957933B1 (en) 2008-05-07
IL128318A0 (en) 2000-01-31
PL331424A1 (en) 1999-07-19
EP1623720A2 (en) 2006-02-08
EP1623720A3 (en) 2006-02-22
UA68336C2 (en) 2004-08-16
CN1241639C (zh) 2006-02-15
NO990464L (no) 1999-02-01
WO1998005355A1 (en) 1998-02-12
CA2262402A1 (en) 1998-02-12
NO319844B1 (no) 2005-09-19
AR008799A1 (es) 2000-02-23
EP0957933A1 (en) 1999-11-24
US20060292170A1 (en) 2006-12-28
AP9901448A0 (en) 1999-03-31
CZ290826B6 (cs) 2002-10-16
MY116128A (en) 2003-11-28
SK11599A3 (en) 2000-03-13
ATE394119T1 (de) 2008-05-15
PL188741B1 (pl) 2005-04-29
SK282438B6 (sk) 2002-02-05
EA002167B1 (ru) 2002-02-28
OA10969A (en) 2003-03-04
CN1231613A (zh) 1999-10-13
PE97298A1 (es) 1999-02-14
KR20000029747A (ko) 2000-05-25
ZA976815B (en) 1998-05-11
IL128318A (en) 2002-04-21
TR199900195T2 (xx) 1999-04-21
EA199900069A1 (ru) 1999-10-28
AU4204097A (en) 1998-02-25
DZ2283A1 (fr) 2002-12-25
CO4650186A1 (es) 1998-09-03
NO990464D0 (no) 1999-02-01
AP1166A (en) 2003-06-30
AU706303B2 (en) 1999-06-10
BR9710913A (pt) 1999-08-17
BG103141A (en) 1999-08-31
GB9616351D0 (en) 1996-09-11
CZ29299A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
NO985460D0 (no) Limsammensetning
BR9711853A (pt) Vacinas
DE69718508D1 (de) Antitraspirant zusammensetzung
NO20004758L (no) Vaksinesammensetning
NO20003303L (no) Vaksine
DE69721231D1 (de) Anisotrop leitende zusammensetzung
ID18090A (id) Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
NO983153L (no) Tannbaarste
ID18359A (id) Komposisi mikrokapsul
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
DE69733072D1 (de) Farbschonende zusammensetzungen
DZ2283A1 (fr) Composition de vaccin.
ID19589A (id) Komposisi
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
FI972054A7 (fi) Immunogeenisiä koostumuksia
BR9707835A (pt) Composiç
ID18698A (id) Komposisi farmasi
BR9709815A (pt) Composicão
ID19246A (id) Komposisi oral antikalkulus
NO983479D0 (no) Sementsammensetning
ID19099A (id) Komposisi oral
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
KR970007831U (ko) 김밥 말이용 김발
NO991735D0 (no) Vaskemiddelblanding